CCA
TWST icon

Cypress Capital Advisors’s Twist Bioscience TWST Stock Holding History

Cypress Capital Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$446K Hold
4,339
– – 0.18% 62
2026
Q1 		$206K Buy
+4,339
New +$195K 0.11% 74
2025
Q3 		– Sell
-5,550
Closed -$204K – 76
2025
Q2 		$204K Sell
5,550
-27
-0.5% -$933 0.13% 69
2025
Q1 		$219K Hold
5,577
– – 0.15% 70
2024
Q4 		$259K Buy
+5,577
New +$252K 0.2% 54

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Cypress Capital Advisors's TWST Position: Q2 2026 in Review

Cypress Capital Advisors held its Twist Bioscience (TWST) position steady in Q2 2026 at 4,339 shares worth $446K. The position accounts for 0.18% of the portfolio, ranked #62.

Cypress Capital Advisors first reported a position in TWST in Q4 2024 and has held it in 5 quarters since. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Cypress Capital Advisors held 4,339 shares of Twist Bioscience worth $446K as of Q2 2026.
  • Cypress Capital Advisors left its Twist Bioscience share count unchanged in Q2 2026.
  • Twist Bioscience made up 0.18% of Cypress Capital Advisors's portfolio in Q2 2026, its #62 holding.
  • Cypress Capital Advisors first reported a position in Twist Bioscience in Q4 2024 and has held it in 5 quarters since.
  • 336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Cypress Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.